These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 30825491)

  • 1. The α2,3-selective potentiator of GABA
    Witkin JM; Cerne R; Davis PG; Freeman KB; do Carmo JM; Rowlett JK; Methuku KR; Okun A; Gleason SD; Li X; Krambis MJ; Poe M; Li G; Schkeryantz JM; Jahan R; Yang L; Guo W; Golani LK; Anderson WH; Catlow JT; Jones TM; Porreca F; Smith JL; Knopp KL; Cook JM
    Pharmacol Biochem Behav; 2019 May; 180():22-31. PubMed ID: 30825491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The α2,3-selective potentiators of GABA
    Biggerstaff A; Kivell B; Smith JL; Mian MY; Golani LK; Rashid F; Sharmin D; Knutson DE; Cerne R; Cook JM; Witkin JM
    Pharmacol Biochem Behav; 2020 Sep; 196():172996. PubMed ID: 32668266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Positive Allosteric Modulator of
    Witkin JM; Li G; Golani LK; Xiong W; Smith JL; Ping X; Rashid F; Jahan R; Cerne R; Cook JM; Jin X
    J Pharmacol Exp Ther; 2020 Jan; 372(1):83-94. PubMed ID: 31694876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioisosteres of ethyl 8-ethynyl-6-(pyridin-2-yl)-4H-benzo[f]imidazo [1,5-a][1,4]diazepine-3-carboxylate (HZ-166) as novel alpha 2,3 selective potentiators of GABA
    Witkin JM; Smith JL; Ping X; Gleason SD; Poe MM; Li G; Jin X; Hobbs J; Schkeryantz JM; McDermott JS; Alatorre AI; Siemian JN; Cramer JW; Airey DC; Methuku KR; Tiruveedhula VVNPB; Jones TM; Crawford J; Krambis MJ; Fisher JL; Cook JM; Cerne R
    Neuropharmacology; 2018 Jul; 137():332-343. PubMed ID: 29778948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the α2/α3-subtype-selective GABAA receptor positive allosteric modulator KRM-II-81 on pain-depressed behavior in rats: comparison with ketorolac and diazepam.
    Moerke MJ; Li G; Golani LK; Cook J; Negus SS
    Behav Pharmacol; 2019 Aug; 30(5):452-461. PubMed ID: 30640180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antinociceptive Effects of
    Lewter LA; Woodhouse K; Tiruveedhula VVNPB; Cook JM; Li JX
    J Pharmacol Exp Ther; 2024 Nov; 391(3):389-398. PubMed ID: 38670800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antinociceptive Effects of a Novel α2/α3-Subtype Selective GABA
    Lewter LA; Fisher JL; Siemian JN; Methuku KR; Poe MM; Cook JM; Li JX
    ACS Chem Neurosci; 2017 Jun; 8(6):1305-1312. PubMed ID: 28150939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imidazodiazepine Anticonvulsant, KRM-II-81, Produces Novel, Non-diazepam-like Antiseizure Effects.
    Knutson DE; Smith JL; Ping X; Jin X; Golani LK; Li G; Tiruveedhula VVNPB; Rashid F; Mian MY; Jahan R; Sharmin D; Cerne R; Cook JM; Witkin JM
    ACS Chem Neurosci; 2020 Sep; 11(17):2624-2637. PubMed ID: 32786313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolism, pharmacokinetics, and anticonvulsant activity of a deuterated analog of the α2/3-selective GABAkine KRM-II-81.
    Golani LK; Divović B; Sharmin D; Pandey KP; Mian MY; Cerne R; Zahn NM; Meyer MJ; Tiruveedhula VVNPB; Smith JL; Ping X; Jin X; Lippa A; Schkeryantz JM; Arnold LA; Cook JM; Savić MM; Witkin JM
    Biopharm Drug Dispos; 2022 Apr; 43(2):66-75. PubMed ID: 35194800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New Imidazodiazepine Analogue, 5-(8-Bromo-6-(pyridin-2-yl)-4
    Sharmin D; Divović B; Ping X; Cerne R; Smith JL; Rezvanian S; Mondal P; Meyer MJ; Kiley ME; Arnold LA; Mian MY; Pandey KP; Jin X; Mitrović JR; Djorović D; Lippa A; Cook JM; Golani LK; Scholze P; Savić MM; Witkin JM
    ACS Chem Neurosci; 2024 Feb; 15(3):517-526. PubMed ID: 38175916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GABAA α5 subunit-containing receptors do not contribute to reversal of inflammatory-induced spinal sensitization as indicated by the unique selectivity profile of the GABAA receptor allosteric modulator NS16085.
    de Lucas AG; Ahring PK; Larsen JS; Rivera-Arconada I; Lopez-Garcia JA; Mirza NR; Munro G
    Biochem Pharmacol; 2015 Feb; 93(3):370-9. PubMed ID: 25542996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An antidepressant-related pharmacological signature for positive allosteric modulators of α2/3-containing GABA
    Methuku KR; Li X; Cerne R; Gleason SD; Schkeryantz JM; Tiruveedhula VVNPB; Golani LK; Li G; Poe MM; Rahman MT; Cook JM; Fisher JL; Witkin JM
    Pharmacol Biochem Behav; 2018 Jul; 170():9-13. PubMed ID: 29715490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abuse-related effects of subtype-selective GABA
    Schwienteck KL; Li G; Poe MM; Cook JM; Banks ML; Stevens Negus S
    Psychopharmacology (Berl); 2017 Jul; 234(14):2091-2101. PubMed ID: 28365836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A question of balance--positive versus negative allosteric modulation of GABA(A) receptor subtypes as a driver of analgesic efficacy in rat models of inflammatory and neuropathic pain.
    Munro G; Erichsen HK; Rae MG; Mirza NR
    Neuropharmacology; 2011; 61(1-2):121-32. PubMed ID: 21439986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The imidazodiazepine, KRM-II-81: An example of a newly emerging generation of GABAkines for neurological and psychiatric disorders.
    Witkin JM; Lippa A; Smith JL; Jin X; Ping X; Biggerstaff A; Kivell BM; Knutson DE; Sharmin D; Pandey KP; Mian MY; Cook JM; Cerne R
    Pharmacol Biochem Behav; 2022 Feb; 213():173321. PubMed ID: 35041859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural Analogs of the GABAkine KRM-II-81 Are Orally Bioavailable Anticonvulsants without Sedation.
    Pandey KP; Divović B; Rashid F; Golani LK; Cerne R; Zahn NM; Meyer MJ; Arnold LA; Sharmin D; Mian MY; Smith JL; Ping X; Jin X; Lippa A; Tiruveedhula VVNPB; Cook JM; Savić MM; Witkin JM
    J Pharmacol Exp Ther; 2023 Apr; 385(1):50-61. PubMed ID: 36746611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the novel subtype-selective GABAA receptor-positive allosteric modulator NS11394 [3'-[5-(1-hydroxy-1-methyl-ethyl)-benzoimidazol-1-yl]-biphenyl-2-carbonitrile] with diazepam, zolpidem, bretazenil, and gaboxadol in rat models of inflammatory and neuropathic pain.
    Munro G; Lopez-Garcia JA; Rivera-Arconada I; Erichsen HK; Nielsen EØ; Larsen JS; Ahring PK; Mirza NR
    J Pharmacol Exp Ther; 2008 Dec; 327(3):969-81. PubMed ID: 18791060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positive allosteric modulation of GABA-A receptors reduces capsaicin-induced primary and secondary hypersensitivity in rats.
    Hansen RR; Erichsen HK; Brown DT; Mirza NR; Munro G
    Neuropharmacology; 2012 Dec; 63(8):1360-7. PubMed ID: 22985969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacology in translation: the preclinical and early clinical profile of the novel α2/3 functionally selective GABA
    Nickolls SA; Gurrell R; van Amerongen G; Kammonen J; Cao L; Brown AR; Stead C; Mead A; Watson C; Hsu C; Owen RM; Pike A; Fish RL; Chen L; Qiu R; Morris ED; Feng G; Whitlock M; Gorman D; van Gerven J; Reynolds DS; Dua P; Butt RP
    Br J Pharmacol; 2018 Feb; 175(4):708-725. PubMed ID: 29214652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative anticonvulsant activity of the GABAkine KRM-II-81 and a deuterated analog.
    Ping X; Meyer MJ; Zahn NM; Golani LK; Sharmin D; Pandey KP; Revanian S; Mondal P; Jin X; Arnold LA; Cerne R; Cook JM; Divović B; Savić MM; Lippa A; Smith JL; Witkin JM
    Drug Dev Res; 2023 May; 84(3):527-531. PubMed ID: 36748904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.